Alphamab Oncology (HKSE:09966) Price-to-Owner-Earnings

: (As of Today)

View and export this data going back to 2019. Start your Free Trial

As of today (2023-03-23), Alphamab Oncology's share price is HK$14.64. Alphamab Oncology does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.

The historical rank and industry rank for Alphamab Oncology's Price-to-Owner-Earnings or its related term are showing as below:

As of today (2023-03-23), Alphamab Oncology's share price is HK$14.64. Alphamab Oncology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was HK$-0.37. Therefore, Alphamab Oncology's PE Ratio for today is At Loss.

As of today (2023-03-23), Alphamab Oncology's share price is HK$14.64. Alphamab Oncology's EPS without NRI for the trailing twelve months (TTM) ended in was HK$-0.37. Therefore, Alphamab Oncology's PE Ratio without NRI for today is At Loss.

Alphamab Oncology Price-to-Owner-Earnings Historical Data

The historical data trend for Alphamab Oncology's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Price-to-Owner-Earnings

Alphamab Oncology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Price-to-Owner-Earnings						-	-	-	-	-

Competitive Comparison

For the Biotechnology subindustry, Alphamab Oncology's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Alphamab Oncology Price-to-Owner-Earnings Distribution

For the Biotechnology industry and Healthcare sector, Alphamab Oncology's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Alphamab Oncology's Price-to-Owner-Earnings falls in comparison to its industry or sector. The grey bar indicates the Price-to-Owner-Earnings's extreme value range as defined by GuruFocus.

Alphamab Oncology Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Alphamab Oncology's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings	=	Share Price	/	Owner Earnings per Share (TTM)
	=	14.64	/	-0.56
	=

Alphamab Oncology (HKSE:09966) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Alphamab Oncology Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Alphamab Oncology's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphamab Oncology (HKSE:09966) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (HKSE:09966) » Definitions » Price-to-Owner-Earnings

Traded in Other Exchanges

3NK:Germany

Address

No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215024

Website

http://www.alphamabonc.com

Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in discovery, development manufacturing and commercialization of biotherapeutics for cancer treatment.

Alphamab Oncology (HKSE:09966) Headlines

No Headlines